Wegovy
Songdo Dermatology · Central Park Station Dermatology, Oun Clinic Songdo Branch
Wegovy Treatment Summary
Wegovy® (semaglutide) injection is a prescription injectable designed to aid weight loss and reduce cardiovascular risk in adults with obesity and overweight. It mimics the GLP-1 hormone to suppress appetite and control blood sugar levels. When used with a low-calorie diet and exercise, an average weight loss of 15% over approximately 68 weeks can be expected.
Songdo Dermatology · Central Park Station Dermatology, Oun Clinic Songdo Branch
Wegovy Treatment Features
-
You can easily manage your weight with a once-weekly self-injection.
-
It helps with long-term weight management, making it effective for maintaining weight after weight loss.
Songdo Dermatology · Central Park Station Dermatology, Oun Clinic Songdo Branch
Wegovy Treatment Principle
Wegovy works similarly to the GLP-1 (glucagon-like peptide-1) hormone, influencing the brain's appetite regulation centers. This reduces hunger and prolongs feelings of fullness, naturally reducing food intake and promoting weight loss. It also helps regulate blood sugar levels, benefiting patients with type 2 diabetes.
Songdo Dermatology · Central Park Station Dermatology, Oun Clinic Songdo Branch
Recommended for Wegovy
-
Patients with obesity (BMI of 30 or higher)
-
Those seeking long-term weight management
-
Patients with heart disease and obesity
-
Those who want to prevent complications related to weight
-
People struggling with weight loss through diet and exercise alone
Songdo Dermatology · Central Park Station Dermatology, Oun Clinic Songdo Branch
Wegovy Treatment Time
Treatment Time
5~10 minutes
Frequency
1 week
Recovery Time
Same day
Songdo Dermatology · Central Park Station Dermatology, Oun Clinic Songdo Branch
Wegovy Treatment Process
Step 1
Consultation
Step 2
Wegovy Prescription
Songdo Dermatology · Central Park Station Dermatology, Oun Clinic Songdo Branch
Wegovy Treatment Areas
Abdomen, Arms, Thighs
Songdo Dermatology · Central Park Station Dermatology, Oun Clinic Songdo Branch
Wegovy Precautions
- Wegovy is not recommended for children under 12 as its safety and efficacy have not been confirmed.
- Do not combine Wegovy with other semaglutide-based products or GLP-1 receptor agonists.
- Common side effects include nausea, vomiting, diarrhea, constipation, and abdominal pain, which tend to subside over time.
- Serious side effects such as thyroid tumors, pancreatitis, and gallbladder issues can occur, and it should not be used by patients with certain thyroid conditions.
FAQ
Wegovy injections are most effective when combined with a low-calorie diet and regular physical activity.
Wegovy may increase the risk of hypoglycemia when used with diabetes medications. Patients taking diabetes drugs should consult a doctor to adjust the dosage appropriately.